Pharmacogenetics and pharmacogenomics: Tailored drug therapy for the 21st century

Trends in Pharmacological Sciences

Volumn 22, Issue 1, 2001, Pages 3-4

  Grant, S F A ^a  

^a Axaron Bioscience AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AZATHIOPRINE; CHOLESTEROL ESTER TRANSFER PROTEIN; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; STATIN; THIOPURINE METHYLTRANSFERASE;

CONFERENCE PAPER; DRUG DISPOSITION; DRUG EFFICACY; DRUG METABOLISM; DRUG SENSITIVITY; GENE MAPPING; GENE SEQUENCE; GENETIC ORGANIZATION; GENOTYPE; HAPLOTYPE; HEART INFARCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PHARMACOGENETICS; PHARMACOGENOMICS; PRIORITY JOURNAL; SIDE EFFECT; SINGLE NUCLEOTIDE POLYMORPHISM;

DRUG DESIGN; ECONOMICS, PHARMACEUTICAL; HUMANS; PHARMACOGENETICS;

EID: 0035129854     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(00)01606-0     Document Type: Conference Paper

References (3)

1. Pharmacogenomics: Translating functional genomics into rational therapeutics
2. 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness
3. SNPing away at complex diseases: Analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease